Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Greater than 17 years of age~Exclusion Criteria:~* Concurrent treatment, or within the past 12 months, with drugs known to affect bone metabolism~* Hypocalcemia~* Renal impairment (creatinine \>1.5x ULN)

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).